NCT06487546

Repletion of Ergothioneine in Patients With Kidney Failure

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 28 (estimated)
• Sponsor: Stanford University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Dialysis removes potentially harmful chemicals from the blood but can also remove potentially valuable chemicals. One potentially valuable chemical called ergothioneine, which comes from the diet, is low in the blood of people receiving dialysis. For this research study, the investigators hope to learn how well a daily ergothioneine supplement will replenish the levels in the blood of people with kidney failure.

Conditions

• Esrd

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Ergothioneine	Participants will receive ergothioneine capsule daily for 12 weeks.
OTHER	Placebo	Participants will receive placebo capsule daily for 12 weeks.

Timeline

• Start date: 2025-04-01
• Primary completion: 2029-04-01
• Completion: 2030-12-01
• First posted: 2024-07-05
• Last updated: 2026-04-01

Locations

1 site across 1 country: United States